Insights

Cardiomyopathy patients were classified using cardio, respiratory, and vascular variability. Support vector machine models accurately distinguished between ischemic and dilated cardiomyopathy, and between patients and controls.

Area of Science:

  • Cardiology
  • Biomedical Engineering
  • Physiology

Background:

  • Heart disease is a leading cause of death globally.
  • Diagnosing the specific cause of cardiomyopathies remains difficult.
  • Cardiomyopathy patients exhibit distinct physiological variability patterns.

Purpose of the Study:

  • To classify cardiomyopathy patients using variability analysis.
  • To differentiate between ischemic (ICM) and dilated (DCM) cardiomyopathy.
  • To assess baroreflex response through vascular activity.

Main Methods:

  • Analysis of electrocardiographic, respiratory, and blood pressure signals.
  • Extraction of beat-to-beat intervals (BBI), respiratory cycle time (TT), systolic (SBP), and diastolic (DBP) blood pressure.
  • Geometric and statistical characterization of cardiorespiratory and vascular activity.
  • Support vector machine (SVM) model development for classification.

Main Results:

  • Optimal SVM model achieved 92.7% accuracy for ICM vs. DCM classification.
  • SVM model achieved 86.2% accuracy when comparing cardiomyopathy patients (CMP) to controls (CON).
  • Classification accuracy, sensitivity, and specificity were high for both comparisons.

Conclusions:

  • Cardio, respiratory, and vascular variability analysis effectively classifies cardiomyopathy subtypes.
  • Physiological variability patterns differ significantly between ICM and DCM patients.
  • Patients show impaired regulation of vascular variability, indicating limited baroreflex response.

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
347
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
270
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
297
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
231
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
176
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
183